Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Bratislava

276 clinical trials in Bratislava, Slovakia across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Bratislava at a glance
276
clinical trials
  • Research sites6
Type of trial
Recruitment status
Quick filters

276 trials in Bratislava

Open in trial search
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:SlovakiaSlovakia
  • Participants:0–17 years
  • Substances:Indacaterol Acetate
  • Sponsor:Novartis Pharma AG
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Dextromethorphan Hydrobromide
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Bratislava

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on non-small cell lung cancer and advanced breast cancer treatments. Studies include evaluation of novel therapies like sigvotatug vedotin and investigations into treatment combinations for metastatic prostate cancer.

  • Lung Cancer Therapeutics
  • Breast Cancer Treatment
  • Prostate Cancer Research

Research includes evaluations of combination therapies and targeted treatments for various stages of cancer.

02 Cardiovascular Studies

Comprehensive research into heart failure prevention and treatment of cardiovascular diseases. Studies examine innovative approaches using medications like baxdrostat and investigating treatments for patients following heart attacks.

  • Heart Failure Prevention
  • Post-Heart Attack Care
  • Cardiovascular Risk Management

Focus on developing preventive strategies and improving patient outcomes in cardiovascular conditions.

03 Inflammatory Conditions

Studies addressing various inflammatory conditions including Crohn's disease and ulcerative colitis. Research evaluates new therapeutic approaches for chronic inflammatory disorders and autoimmune conditions.

  • Inflammatory Bowel Disease
  • Hidradenitis Suppurativa
  • Chronic Inflammatory Disorders

Trials aim to improve treatment options and quality of life for patients with chronic inflammatory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).